As the Australian stock market hovers just above flat, with recent surges pushing the ASX past 9,000 points, investors are keenly observing how global economic indicators and local earnings reports might impact their portfolios. In this environment, dividend stocks can offer a stable income stream and potential for capital appreciation, making them an attractive option for those looking to balance growth with regular returns. Top 10 Dividend Stocks In Australia Name Dividend Yield Dividend Rating Vita Life Sciences (ASX:VLS) 3.83% ★★★★★☆ Treasury Wine Estates (ASX:TWE) 7.56% ★★★★★☆ Super Retail Group (ASX:SUL) 6.58% ★★★★★☆ Sugar Terminals (NSX:SUG) 8.46% ★★★★★☆ Steadfast Group (ASX:SDF) 4.46% ★★★★★☆ Smartgroup (ASX:SIQ) 6.08% ★★★★★☆ MFF Capital Investments (ASX:MFF) 3.83% ★★★★★☆ Kina Securities (ASX:KSL) 7.51% ★★★★★☆ Fiducian Group (ASX:FID) 4.87% ★★★★★☆ Accent Group (ASX:AX1) 7.73% ★★★★★☆ Click here to see the full list of 35 stocks from our Top ASX Dividend Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. ASX Simply Wall St Dividend Rating: ★★★★☆☆ Overview: ASX Limited operates as a multi-asset class and integrated exchange company in Australia and internationally with a market cap of A$10.57 billion. Operations: ASX Limited generates revenue through its operations as a multi-asset class and integrated exchange company, serving both domestic and international markets. Dividend Yield: 4.1% ASX Limited's recent announcement of an 8.5% reduction in its interim dividend to A$1.018 per share, reflecting a payout ratio decrease from 85% to 75%, highlights its volatile dividend history despite past growth over a decade. While the current cash payout ratio of 80.2% ensures dividends are covered by cash flows, the yield remains lower than top-tier Australian dividend stocks at 4.1%. The company's earnings and revenue have shown modest growth, but leadership changes could impact future stability. Click here to discover the nuances of ASX with our detailed analytical dividend report. The analysis detailed in our ASX valuation report hints at an inflated share price compared to its estimated value.ASX:ASX Dividend History as at Feb 2026 Servcorp Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Servcorp Limited offers executive serviced and virtual offices, coworking spaces, and a range of IT, communications, and secretarial services across multiple regions including Australia, New Zealand, Southeast Asia, the United States, Europe, the Middle East, North Asia and beyond; it has a market cap of A$720.52 million. Operations: Servcorp Limited generates revenue primarily from its Real Estate - Rental segment, amounting to A$349.86 million. Story Continues Dividend Yield: 3.9% Servcorp's dividend payments have increased over the past decade, covered by both earnings (52% payout ratio) and cash flows (14.7% cash payout ratio), despite a volatile history. Trading at 30% below its estimated fair value, it offers good relative value compared to peers. However, with a yield of 3.88%, it falls short of top-tier Australian dividend stocks. Recent guidance raised expected earnings for 2026 to A$80-84 million, indicating potential growth stability. Navigate through the intricacies of Servcorp with our comprehensive dividend report here. According our valuation report, there's an indication that Servcorp's share price might be on the cheaper side.ASX:SRV Dividend History as at Feb 2026 Vita Life Sciences Simply Wall St Dividend Rating: ★★★★★☆ Overview: Vita Life Sciences Limited is a healthcare company involved in formulating, packaging, distributing, and selling vitamins and supplements across Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China with a market cap of A$142.56 million. Operations: Vita Life Sciences Limited generates revenue through the formulation, packaging, distribution, and sale of vitamins and supplements in various countries including Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. Dividend Yield: 3.8% Vita Life Sciences offers a stable dividend yield of 3.83%, which is lower than the top Australian payers but remains reliable with consistent growth over the past decade. The dividends are well-covered by both earnings (66.5% payout ratio) and cash flows (59.5% cash payout ratio). Trading at 35.2% below its fair value, VLS presents potential value for investors seeking steady income despite not being among the highest-yielding options in Australia. Delve into the full analysis dividend report here for a deeper understanding of Vita Life Sciences. Our expertly prepared valuation report Vita Life Sciences implies its share price may be lower than expected.ASX:VLS Dividend History as at Feb 2026 Taking Advantage Click here to access our complete index of 35 Top ASX Dividend Stocks. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Looking For Alternative Opportunities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ASX ASX:SRV and ASX:VLS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Top ASX Dividend Stocks To Consider In February 2026
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...